DNA Methylation Age Acceleration Mediates the Relationship between Systemic Inflammation and Cognitive Impairment
Authors:
- César Higgins TejeraCTCésar Higgins Tejera
- Peiyao ZhuPZPeiyao Zhu
- Erin B. WareEWErin B. Ware
- Margaret T. HickenMHMargaret T. Hicken
- Matthew ZawistowskiMZMatthew Zawistowski
- Lindsay C. KobayashiLKLindsay C. Kobayashi
- Dominika SeblovaDSDominika Seblova
- Jennifer ManlyJMJennifer Manly
- Bhramar MukherjeeBMBhramar Mukherjee
- Kelly M. BakulskiKBKelly M. Bakulski
Preprint
Abstract
Background Chronic inflammation and DNA methylation are potential mechanisms in dementia etiology. The linkage between inflammation and DNA methylation age acceleration in shaping dementia risk is understudied. We explored the association of inflammatory cytokines with cognitive impairment and whether DNA methylation age acceleration mediates this relationship. Methods In a subset of the 2016 wave of the Health and Retirement Study (n=3,346, age>50), we employed logistic regression to estimate the associations between each inflammatory cytokine (interleukin-6 (IL-6), C-reactive protein (CRP), and insulin-like growth factor-1 (IGF-1)), and both Langa-Weir classified cognitive impairment non-dementia and dementia, respectively. We calculated DNA methylation age acceleration residuals by regressing GrimAge on chronologic age. We tested if DNA methylation age acceleration mediated the relationship between systemic inflammation and cognitive impairment, adjusting for sociodemographic, behavioral factors, chronic conditions, and cell type proportions. Results The prevalence of cognitive impairment was 16%. In the fully-adjusted model, participants with a doubling of IL-6 levels had 1.12 (95% CI: 1.02-1.22) times higher odds of cognitive impairment. Similar associations were found for CRP and IGF-1. Participants with a doubling of IL-6 levels had 0.77 (95% CI: 0.64, 0.90) years of GrimAge acceleration. In mediation analyses with each cytokine as predictor separately, 17.7% (95% CI: 7.0%, 50.9%) of the effect of IL-6 on cognitive impairment was mediated through DNA methylation age acceleration. Comparable mediated estimates were found for CRP and IGF-1. Conclusions Systemic inflammation is associated with cognitive impairment, with suggestive evidence that this relationship is partially mediated through DNA methylation age acceleration.Keywords
This publication has 44 references indexed in Scilit:
- The structural and social determinants of Alzheimer's disease related dementiasAlzheimer's & Dementia, 2023
- A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational StudiesJAMA, 2021
- Immune senescence, epigenetics and autoimmunityClinical Immunology, 2018
- Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's diseaseAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2018
- Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literatureAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2016
- Neuroinflammation in Alzheimer's disease: Current evidence and future directionsAlzheimer's & Dementia, 2016
- Inequalities in dementia incidence between six racial and ethnic groups over 14 yearsAlzheimer's & Dementia, 2016
- The Hallmarks of AgingCell, 2013
- Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging RatesMolecular Cell, 2013
- Inflammatory Proteins in Plasma and the Risk of DementiaArchives of Neurology, 2004